Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic
https://doi.org/10.31631/2073-3046-2024-23-1-51-56
Abstract
Relevance. The etiological structure of community-acquired pneumonia (CAP) with the widespread COVID-19 as backdrop is poorly studied. Aim. Comparative study of community-acquired pneumonia etiological structure in patients with and without a new coronavirus infection. Materials and methods. The etiology of CAP was estimated on the base of the results of bacteriological and molecular genetic studies of sputum samples and swabs from the posterior pharyngeal wall in 142 children and 190 adults in 1- 2 days from the moment they were hospitalized to two medical organizations of Perm in the period of 2021-2022 with a primary diagnosis of CAP. There were 131 negative and 11 positive for SARS-CoV-2 among pediatric patients. There were 84 negative and 106 – positive for SARS-CoV-2 among the adults. Results. It was found that in patients with CAP in the presence of COVID19, compared with SARS-CoV-2-negative patients, a more frequent isolation of K. pneumoniae, S. aureus, S. haemolyticus and H. influenzae DNA, as well as microbial associations of bacterial etiology. Conclusion. The results of the study can be used when choosing treatment tactics for combined infections.
About the Authors
V. I. Sergevnin
Perm State Medical University named after Academician E.A. Wagner
Russian Federation
Russian Federation
Victor I. Sergevnin– Dr. Sci. (Med.), Professor of the Department of Hygiene and Epidemiology,
Perm,
tel. +7 (912) 592-91-40.
M. V. Rozhkova
Perm Regional Center for Control and Prevention of AIDS and Infectious Diseases
Russian Federation
Russian Federation
Marina V. Rozhkova – Head of the Organizational and Methodological Department,
Perm,
tel.+7 (950) 458-47-02.
K. V. Ovchinnikov
Perm Regional Center for Control and Prevention of AIDS and Infectious Diseases, Perm, Russia. +7 (992) 214-17-50
Russian Federation
Russian Federation
Kirill V. Ovchinnikov – Chief Medical Officer,
Perm,
tel.+7 (992) 214-17-50.
E. Zh. Kuzovnikova
Perm Center of Hygiene and Epidemiology in Perm Region of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Russian Federation
Russian Federation
Elena Zh. Kuzovnikova – Deputy Chief Physician,
Perm,
tel.+7 (912) 98- 96-814
References
1. Popova A. Yu., Yezhova E. B., Demina Yu. V., et al. Features of the etiology of community-acquired pneumonia associated with COVID-19. Problems of particularly dangerous infections. 2020; 4:99–105. doi: 10.21055/0370-1069-2020-4-99-105 (In Russ.).
2. Stulova M. V., Kudryasheva I. A., Polunina O. S., et al. Comparative clinical and laboratory analysis of COVID-19 associated pneumonia with community-acquired pneumo- nia of bacterial etiology. Modern Problems of Science and Education, 2020; 3:134. doi: 10.17513/spno.29905 (In Russ.).
3. Lai CC., Wang CY., Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020; 53(4): 505–12. doi: 10.1016/j.jmii.2020.05.013.
4. Lucien MAB, Canarie MF, Kilgore PE, et al. Antibiotics and antimicrobial resistance n the COVID-19 era: Perspective from resourcelimited settings. IntJInfectDis. 2021; 104: 250–4. doi: 10.1016/j.ijid.2020.12.087.
5. Portenko S. A., Kazakova E. S., Naidenova E. V., et al. Etiological pattern of community-acquired pneumonia related to the new coronavirus infection covid-19 pandemic in the Saratov region. Infection and immunity. 2022;12 (1): 95–104. doi: 10.15789/2220-7619-AEO-1747 (In Russ.).
6. Di Mitri C, Arcoleo G, Mazzuca E, et al. COVID-19 and non–COVID-19 pneumonia: a comparison. Pulmonary Medicine. 2021.Pages 2321-2331 | Received, Accepted 19 Nov 2021, Published online: 02 Dec 2021. doi: 10.1080/07853890.2021.2010797.
7. Getahun H, Smith I, Trivedi K, et al. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020; 98(7): 442–442A. doi: 10.2471/BLT.20.268573.
8. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; 81(2): 266–75. doi: 10.1016/j.jinf.2020.05.046.
9. Kataeva L.V., Vakorina A.A., Stepanova T.F., Stepanova K.B. Microbiota of the lower respiratory tract in community-acquired pneumonia, including associated with SARSCoV-2. Journal of Microbiology, Epidemiology and Immunobiology. 2021;98(5):528–537. doi: 10.36233/0372-9311-10.7 (In Russ.).
10. Howard ML. Is There an Association Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Streptococcus pneumoniae? Clinical Infectious Diseases, 2021; 72 (5):76–78. doi: 10.1093/cid/ciaa1812.
11. Du Toit A. Measles increases the risk of other infections. Nat Rev Microbiol. 2019; 18(1):2. doi: 10.1038/s41579-019-0301-7.
12. Zhou Y, Guo S, He Y, et al. COVID-19 is distinct from SARS-CoV-2-negative community-acquired pneumonia.FrontCellInfectMicrobiol. 2020; 10:322. doi: 10.3389/fcimb.2020.00322.
Review
For citations:
Sergevnin V.I., Rozhkova M.V., Ovchinnikov K.V., Kuzovnikova E.Zh. Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic. Epidemiology and Vaccinal Prevention. 2024;23(1):51-56. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-1-51-56
Views:
540
Email this article 